Statistics
Publications
4
Citations
79
H-Index
4
Active since
2023
Mingming Zheng is an author at Zhejiang University specializing in cancer immunotherapy, oncology, and immune checkpoint regulation.
Publications per year
2023–2024
4
4
The inhibitory effect of adenosine on tumor adaptive immunity and intervention strategies
Longsheng Wang, Jie Zhang, Wenxin Zhang et al. · Acta Pharmaceutica Sinica B · 2023 · 38 citations · Full text
Medicine, Immunology, Oncology +17
Mevalonate improves anti-PD-1/PD-L1 efficacy by stabilizing CD274 mRNA
Wenxin Zhang, Xiaohui Pan, Yanjun Xu et al. · Acta Pharmaceutica Sinica B · 2023 · 16 citations · Full text
Medicine, Oncology, Pharmacology +17
Zosuquidar Promotes Antitumor Immunity by Inducing Autophagic Degradation of PD‐L1
Ling Ding, Hongjie Guo, Jie Zhang et al. · Advanced Science · 2024 · 14 citations · Full text
1–4 of 4